Developer docs
API playgroundTry for free, no card

Search company profiles

Johnson & Johnson Impact Ventures

Full company profile

uuid0008ctw

Namestring
Johnson & Johnson Impact Ventures
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Johnson & Johnson Impact Ventures is a wholly-owned corporate impact investment subsidiary of Johnson & Johnson (NYSE: JNJ), founded in 2019 and headquartered in New Brunswick, United States. The fund invests in purpose-driven entrepreneurs innovating at the front lines of healthcare delivery, with a thematic focus on improving access and outcomes in underserved markets across Africa, the Middle East, and other emerging regions. Its portfolio spans clinic-based primary care (e.g., Penda Health, which provides maternal and child health services in Kenya and delivers quarterly impact reports under a formalized impact measurement and management framework) and AI-enabled digital health (e.g., Rology, an AI-assisted teleradiology platform serving over 300 hospitals across 13 countries, in whose November 2025 growth round J&J Impact Ventures participated alongside Philips Foundation, Sanofi Global Health Unit's Impact Fund, and MIT Solve Innovation Future).

The entity operates with a small team of 1-10 employees and functions as a strategic capital deployment arm of Johnson & Johnson rather than a standalone revenue-generating business. Its core "product" is equity investment combined with the credibility and resources of the J&J parent, including access to the parent's global healthcare network, brand equity, and emerging-market presence. Deal flow and portfolio support are reinforced by a recurring multi-investor syndicate structure, positioning the fund as a co-investor of choice for other major healthcare-aligned impact investors (Philips Foundation, Sanofi Global Health Unit, MIT Solve). There is no disclosed pricing model, external fund-raising, or management-fee structure; capital is sourced internally from Johnson & Johnson.

Input data does not disclose AUM, portfolio company count, ticket sizes, or geographic restrictions, and the fund's own website was inaccessible at the time of capture (returning a maintenance error). The investment thesis appears consistent with J&J's broader global health and environmental, social, and governance (ESG) commitments, emphasizing measurable health outcomes — particularly maternal/child health and healthcare workforce shortages (radiology) — rather than financial returns maximization.

Short descriptiontext

Johnson & Johnson Impact Ventures is the corporate impact investment arm of Johnson & Johnson, funding purpose-driven healthcare startups serving underserved markets in regions such as East Africa and the Middle East. The New Brunswick-based fund deploys capital into portfolio companies across digital health and primary care since 2019.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
10,001+
akta.pro rankint
HeadquartersNew Brunswick, United States
HQ citystring
New Brunswick
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
impact investing, venture capital, healthcare investments, social impact funds, startup funding
Industry3 codes
PRIMARYFSANAJAI
Healthcare Access & Life Sciences Impact Funds
Financial & Insurance/Private Equity & Venture Capital/Impact / ESG & Sustainable Investment Funds
SECONDARYFSANAAAG
Impact / ESG Venture Capital
SECONDARYBPADACAO
Impact Investment & Development Investment Funds
Business & Public Services/International Organizations & Development/International Financial Institutions & Development Banks
NAICS code1 code
  • Portfolio Management and Investment Advice52394
SIC code1 code
  • Investment Advice6282
Product category
Impact Investment / Venture Capital
Social media profiles1 record
Cost components2 values
Personnel, Operations
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Johnson & Johnson Impact Ventures is an impact investment initiative of Johnson & Johnson that deploys capital into purpose-driven healthcare entrepreneurs and startups operating at the front lines of care. The fund participates in growth funding rounds of companies addressing healthcare access gaps in underserved markets, co-investing alongside other strategic healthcare investors such as Philips Foundation and Sanofi Global Health Unit's Impact Fund.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Johnson & Johnson Impact Ventures is an impact investment initiative that provides funding and support to healthcare startups in underserved markets. The available source data focuses on investment recipients (such as Rology and Penda Health) rather than describing Johnson & Johnson Impact Ventures' own product portfolio or service offerings.

Product and service2 records
1Healthcare Impact Investment Capital
CategoryImpact Investment
2Portfolio Impact Measurement and Management
CategoryImpact Management Services
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Co-invested alongside J&J Impact Ventures in Rology's 2025 growth round. Both are corporate-backed impact funds focused on expanding healthcare access in underserved markets, with comparable mandates and co-investment behavior.

TypeDirect peer
Description

Co-led Rology's 2025 growth round with J&J Impact Ventures. Philips Foundation is the impact investing arm of Royal Philips, focused on healthcare access through technology-enabled solutions, making it a directly comparable corporate impact fund.

TypeDirect peer
Description

Novartis's philanthropic and impact arm focuses on expanding access to healthcare in low- and middle-income countries. Closely comparable as a Big Pharma-backed healthcare impact investor with similar global health access mandate.

TypeDirect peer
Description

Merck's venture arm invests in digital health and global health innovation. Comparable as a major pharma corporate investor with healthcare-focused portfolio strategy.

5Boehringer Ingelheim Social Engagement
TypeDirect peer
Description

Boehringer Ingelheim's impact and social engagement programs invest in access-to-healthcare initiatives in underserved regions. Comparable as another large pharma corporate impact investor addressing healthcare access gaps.

TypeDirect peer
Description

Bayer's philanthropic and impact arm invests in health and nutrition innovations globally. Comparable as another large-cap healthcare company's corporate impact investor with similar global health access mandate.

TypeBroad incumbent
Description

Acumen is a pioneering impact investment fund focused on poverty alleviation including healthcare access across Africa and South Asia. Comparable as a larger, more established impact investor in healthcare access for underserved markets.

TypeDirect peer
Description

Medtronic's philanthropic arm invests in expanding access to healthcare technology and chronic disease management. Comparable as a medtech corporate impact investor with global health access focus.

9PATH
TypeBroad incumbent
Description

PATH is a global health organization that invests in and accelerates healthcare innovations for low-resource settings. Comparable as a larger, established global health innovation investor with similar mission.

TypeDirect peer
Description

GSK's impact investing initiatives fund healthcare access and innovation in underserved markets. Comparable as a major pharma corporate impact investor with global health mandate.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment9 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Johnson & Johnson Impact Ventures

Impact Investment / Venture Capitalimpactventures.jnj.com

Johnson & Johnson Impact Ventures is the corporate impact investment arm of Johnson & Johnson, funding purpose-driven healthcare startups serving underserved markets in regions such as East Africa and the Middle East. The New Brunswick-based fund deploys capital into portfolio companies across digital health and primary care since 2019.

What Johnson & Johnson Impact Ventures does

Johnson & Johnson Impact Ventures is a wholly-owned corporate impact investment subsidiary of Johnson & Johnson (NYSE: JNJ), founded in 2019 and headquartered in New Brunswick, United States. The fund invests in purpose-driven entrepreneurs innovating at the front lines of healthcare delivery, with a thematic focus on improving access and outcomes in underserved markets across Africa, the Middle East, and other emerging regions. Its portfolio spans clinic-based primary care (e.g., Penda Health, which provides maternal and child health services in Kenya and delivers quarterly impact reports under a formalized impact measurement and management framework) and AI-enabled digital health (e.g., Rology, an AI-assisted teleradiology platform serving over 300 hospitals across 13 countries, in whose November 2025 growth round J&J Impact Ventures participated alongside Philips Foundation, Sanofi Global Health Unit's Impact Fund, and MIT Solve Innovation Future).

The entity operates with a small team of 1-10 employees and functions as a strategic capital deployment arm of Johnson & Johnson rather than a standalone revenue-generating business. Its core "product" is equity investment combined with the credibility and resources of the J&J parent, including access to the parent's global healthcare network, brand equity, and emerging-market presence. Deal flow and portfolio support are reinforced by a recurring multi-investor syndicate structure, positioning the fund as a co-investor of choice for other major healthcare-aligned impact investors (Philips Foundation, Sanofi Global Health Unit, MIT Solve). There is no disclosed pricing model, external fund-raising, or management-fee structure; capital is sourced internally from Johnson & Johnson.

Input data does not disclose AUM, portfolio company count, ticket sizes, or geographic restrictions, and the fund's own website was inaccessible at the time of capture (returning a maintenance error). The investment thesis appears consistent with J&J's broader global health and environmental, social, and governance (ESG) commitments, emphasizing measurable health outcomes — particularly maternal/child health and healthcare workforce shortages (radiology) — rather than financial returns maximization.

Johnson & Johnson Impact Ventures firmographics

Firmographics
Name
Johnson & Johnson Impact Ventures
Website
https://impactventures.jnj.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
10,001+ employees
Short description
Johnson & Johnson Impact Ventures is the corporate impact investment arm of Johnson & Johnson, funding purpose-driven healthcare startups serving underserved markets in regions such as East Africa and the Middle East. The New Brunswick-based fund deploys capital into portfolio companies across digital health and primary care since 2019.
Ownership category
akta.pro rank

Johnson & Johnson Impact Ventures industry classification

Industry
Product category
Impact Investment / Venture Capital
NAICS
Portfolio Management and Investment Advice (52394)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSANAJAI
Healthcare Access & Life Sciences Impact Funds
Financial & Insurance/Private Equity & Venture Capital/Impact / ESG & Sustainable Investment Funds
SECONDARYFSANAAAG
Impact / ESG Venture Capital
SECONDARYBPADACAO
Impact Investment & Development Investment Funds
Business & Public Services/International Organizations & Development/International Financial Institutions & Development Banks

Keywords

  • Impact investing
  • Venture capital
  • Healthcare investments
  • Social impact funds
  • Startup funding

Where Johnson & Johnson Impact Ventures is headquartered

Location

Headquarters

HQ city
New Brunswick
HQ country
United States
HQ region
North America

Markets served

Johnson & Johnson Impact Ventures business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations

Johnson & Johnson Impact Ventures product offering

Product offering

Core offering

Johnson & Johnson Impact Ventures is an impact investment initiative of Johnson & Johnson that deploys capital into purpose-driven healthcare entrepreneurs and startups operating at the front lines of care. The fund participates in growth funding rounds of companies addressing healthcare access gaps in underserved markets, co-investing alongside other strategic healthcare investors such as Philips Foundation and Sanofi Global Health Unit's Impact Fund.

Product overview

Johnson & Johnson Impact Ventures is an impact investment initiative that provides funding and support to healthcare startups in underserved markets. The available source data focuses on investment recipients (such as Rology and Penda Health) rather than describing Johnson & Johnson Impact Ventures' own product portfolio or service offerings.

Differentiator

Problem solved

Functional benefit

Products and services

  • Healthcare Impact Investment Capital
  • Portfolio Impact Measurement and Management

Companies that use Johnson & Johnson Impact Ventures

Customer profile

Ideal customer profiles1 record

Johnson & Johnson Impact Ventures technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Johnson & Johnson Impact Ventures partnerships and signals

Strategic signal

Recent moves5 records

Expansion highlights4 records

Johnson & Johnson Impact Ventures competitors and assessment

Company assessment

Direct peers

  • Sanofi Global Health Unit's Impact Fund: Co-invested alongside J&J Impact Ventures in Rology's 2025 growth round. Both are corporate-backed impact funds focused on expanding healthcare access in underserved markets, with comparable mandates and co-investment behavior.
  • Philips Foundation: Co-led Rology's 2025 growth round with J&J Impact Ventures. Philips Foundation is the impact investing arm of Royal Philips, focused on healthcare access through technology-enabled solutions, making it a directly comparable corporate impact fund.
  • Novartis Foundation: Novartis's philanthropic and impact arm focuses on expanding access to healthcare in low- and middle-income countries. Closely comparable as a Big Pharma-backed healthcare impact investor with similar global health access mandate.
  • Merck Global Health Innovation Fund: Merck's venture arm invests in digital health and global health innovation. Comparable as a major pharma corporate investor with healthcare-focused portfolio strategy.
  • Boehringer Ingelheim Social Engagement: Boehringer Ingelheim's impact and social engagement programs invest in access-to-healthcare initiatives in underserved regions. Comparable as another large pharma corporate impact investor addressing healthcare access gaps.
  • Bayer Foundation: Bayer's philanthropic and impact arm invests in health and nutrition innovations globally. Comparable as another large-cap healthcare company's corporate impact investor with similar global health access mandate.
  • Medtronic Foundation: Medtronic's philanthropic arm invests in expanding access to healthcare technology and chronic disease management. Comparable as a medtech corporate impact investor with global health access focus.
  • GSK Impact Investments: GSK's impact investing initiatives fund healthcare access and innovation in underserved markets. Comparable as a major pharma corporate impact investor with global health mandate.

Broad incumbents

  • Acumen: Acumen is a pioneering impact investment fund focused on poverty alleviation including healthcare access across Africa and South Asia. Comparable as a larger, more established impact investor in healthcare access for underserved markets.
  • PATH: PATH is a global health organization that invests in and accelerates healthcare innovations for low-resource settings. Comparable as a larger, established global health innovation investor with similar mission.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Johnson & Johnson Impact Ventures social profiles

Digital presence

Johnson & Johnson Impact Ventures financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Johnson & Johnson Impact Ventures leadership team

Management profile

Number of profiles

Johnson & Johnson Impact Ventures funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Johnson & Johnson Impact Ventures M&A and investment

M&A and investment

M&A

Investments9 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Johnson & Johnson Impact Ventures

What does Johnson & Johnson Impact Ventures do?

Johnson & Johnson Impact Ventures is an impact investment initiative of Johnson & Johnson that deploys capital into purpose-driven healthcare entrepreneurs and startups operating at the front lines of care. The fund participates in growth funding rounds of companies addressing healthcare access gaps in underserved markets, co-investing alongside other strategic healthcare investors such as Philips Foundation and Sanofi Global Health Unit's Impact Fund.

Is Johnson & Johnson Impact Ventures a public or private company?

Johnson & Johnson Impact Ventures is a private company. It is classified as corporate owned and is currently operating.

When was Johnson & Johnson Impact Ventures founded?

Johnson & Johnson Impact Ventures was founded in 2019. It employs 10,001+ people.

Where is Johnson & Johnson Impact Ventures based?

Johnson & Johnson Impact Ventures is headquartered in New Brunswick, United States, in the North America region.

Who are Johnson & Johnson Impact Ventures's main competitors?

Direct peers on record are Sanofi Global Health Unit's Impact Fund, Philips Foundation, Novartis Foundation, Merck Global Health Innovation Fund, Boehringer Ingelheim Social Engagement, Bayer Foundation, Medtronic Foundation and GSK Impact Investments. Broad incumbents are Acumen and PATH.

Does Johnson & Johnson Impact Ventures have an API?

No public API is recorded for Johnson & Johnson Impact Ventures.

What industry is Johnson & Johnson Impact Ventures in?

Johnson & Johnson Impact Ventures's product category is Impact Investment / Venture Capital. Its primary akta.pro industry code is FSANAJAI, Healthcare Access & Life Sciences Impact Funds, with a secondary code of FSANAAAG, Impact / ESG Venture Capital. Its NAICS code is 52394 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
TekediaFounders Factory Africa Announces The Raise of $114 Million to Fund African StartupsFounders Factory Africa secured $114 million in funding from investors including the Mastercard Foundation and Johnson & Johnson Impact Ventures to scale its support for African tech startups. The accelerator plans to expand its investment model by adding non-dilutive capital options and strengthening internal venture-building capacity across the continent. Since 2018, the firm has invested in over 55 startups spanning fintech, healthtech, and other sectors in 11 African countries.TechpointFounders Factory Africa secures $114 million to address gender imbalance in the VC ecosystemFounders Factory Africa, an early-stage investor based in South Africa, has secured $114 million in funding from the Mastercard Foundation and Johnson & Johnson Impact Ventures. The firm intends to use this capital to expand its operational support for portfolio companies across the continent, specifically targeting the gender imbalance in venture capital where female-led startups receive a disproportionately small share of funding.Forbes ArgentinaCombaten el cáncer de mama, llegaron a más de medio millón de mujeres y acaban de cerrar la Pre Serie A por US$ 3,3 millonesMamotest, an AI-based mamography platform, closed its Pre Series A at $3.3 million led by Johnson & Johnson Impact Ventures. The company has reached over 650,000 patients in Argentina and Mexico, with 87% of diagnosed women receiving timely treatment. CEO Guillermo Pepe said the funding will enable predictive treatment recommendations.